ZIP insider files Form 144 for 5,553 RSU shares sale on NYSE
Rhea-AI Filing Summary
Form 144 notice indicates a proposed sale of 5,553 common shares on the NYSE through Morgan Stanley Smith Barney, with an aggregate market value of $29,042.19. The shares were acquired as restricted stock units from the issuer on 09/15/2025 and are listed for approximate sale on 09/18/2025. The filing shows aggregated outstanding shares of 74,088,830, so the proposed sale represents roughly 0.0075% of outstanding common shares. The filer also reported two prior 10b5-1 sales by Amy F. Garefis in the past three months: 2,847 shares on 08/18/2025 for $12,493.26 and 2,532 shares on 07/18/2025 for $11,640.62. The form contains customary Rule 144 and 10b5-1 attestations but does not specify the issuer name or the filing date.
Positive
- Use of 10b5-1 plans for prior sales indicates preplanned, compliant insider trading procedures
- Brokered sale through Morgan Stanley Smith Barney shows professional execution and record-keeping
Negative
- None.
Insights
TL;DR Small officer/director/affiliate sale of RSUs; immaterial to capitalization but shows insider liquidity activity.
The filing documents a proposed disposition of 5,553 shares valued at $29,042.19, representing approximately 0.0075% of the 74.09 million shares outstanding. The shares were acquired as restricted stock units on 09/15/2025 and are to be sold through Morgan Stanley Smith Barney on or about 09/18/2025. Two prior 10b5-1 plan sales by Amy F. Garefis in July and August 2025 totaled 5,379 shares for $24,133.88, indicating ongoing, preplanned insider sales rather than opportunistic trading. Given the very small percentage relative to outstanding shares, there is no material impact on the company’s capitalization or liquidity profile.
TL;DR Filing reflects standard insider compliance with Rule 144 and use of 10b5-1 plans; limited governance signal beyond routine compensation monetization.
The notice shows the sale of recently vested RSUs and references 10b5-1 sales by an insider, which suggests use of pre-established trading plans and formal broker handling. Absence of the issuer name and the date of notice in the provided extract limits assessment of timing and disclosure completeness. From a governance perspective, recorded 10b5-1 activity is a normal mechanism for insiders to diversify compensation while minimizing concerns about opportunistic timing, and the transaction size is immaterial to shareholders.